OncoSil Medical Limited (ASX:OSL)

Australia · Delayed Price · Currency is AUD

0.7500

+0.0500 (7.14%)

Oct 27, 2026, 3:18 PM AEDT

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
Device development for new medical treatments	5.09M	1.54M	1.57M	1.47M	1.06M
Total	5.09M	1.54M	1.57M	1.47M	1.06M

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
Australia	91.36K	15.00K	60.00K	-	-
Europe	1.40M	869.56K	456.63K	111.79K	-
Middle East	189.10K	286.23K	-	-	-
APAC (Australia and New Zealand)	-	-	-	255.89K	231.79K
Total	1.68M	1.17M	516.63K	367.68K	231.79K